OnKure Therapeutics (OKUR) Earnings Date & Reports

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

OKUR is expected to report earnings to rise 64.52% to -50 cents per share on November 05

OnKure Therapeutics OKUR Stock Earnings Reports

Q3'26

Est.

$-0.51

Q2'26

Beat

by $0.36

Q1'26

Missed

by $0.05

Q4'25

Missed

by $0.80

Q3'25

Missed

by $0.78

The last earnings report on August 04 showed earnings per share of -31 cents, beating the estimate of -67 cents. With 210.96K shares outstanding, the current market capitalization sits at 113.66M.

View a ticker or compare two or three

OKUR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for OKUR